循环节律和乳腺癌:从分子水平到治疗进步
Dou-Dou Li1, Teng Zhou2, Jing Gao1
1School of Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Journal of cancer research and clinical oncology
|September 12, 2024
概括
昼夜节律 (人体内钟) 的干扰显著影响乳腺癌的发展和进展. 了解这些内部时钟为改善患者的治疗结果提供了新的治疗策略.
科学领域:
- 时间生物学 时间生物学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 循环节律是调节生理过程的内源生物钟.
- 循环节障碍越来越多地被认为是乳腺癌发展和进展的一个因素.
- 本综述探讨了昼夜节律和乳腺瘤发生之间的多方面的相互作用.
研究的目的:
- 为提供关于乳腺癌中昼夜节律扰乱的综合性审查.
- 检查昼夜基因,瘤微环境和遗传多态化的作用.
- 讨论针对昼夜节律的新型治疗策略.
主要方法:
- 审查流行病学证据,将生活方式因素与昼夜干扰和乳腺癌风险联系起来.
- 对关键昼夜基因 (CLOCK,BMAL1,PER,CRY) 在乳腺癌生物学中的作用的分析.
- 研究昼夜失调对瘤微环境和转移的影响.
- 探索昼夜基因多态和乳腺癌易感性之间的关联.
主要成果:
- 外部因素,如夜班工作和饮食扰乱昼夜平衡,影响乳腺癌风险.
- 关键的昼夜基因在乳腺癌中起着关键的作用,提供了潜在的治疗点.
- 循环节律失调促进瘤的进展,上皮细胞-介质细胞过渡,炎症和免疫抑制.
- 循环基因多态性与乳腺癌易感性有关,使得个性化风险评估成为可能.
结论:
- 昼夜节律在乳腺癌的发病过程中至关重要.
- 像慢性疗法和黑激素管理这样的创新疗法显示出有前途.
- 利用昼夜节律为提高乳腺癌治疗效率和患者治疗结果提供了新的途径.
相关概念视频
02:19Circadian Rhythms and Gene Regulation
4.0K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.0K
02:39Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:18Cancer
48.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.2K